로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Neprilysin

Neprilysin

요약

Name:Neprilysin
Target Synonym:EC:3.4.24.11,EC 3.4.24,Atriopeptidase,NEP,SFE,Membrane Metallo-Endopeptidase (Neutral Endopeptidase, Enkephalinase, CALLA, CD10),Membrane Metallo-Endopeptidase Variant 1,Membrane Metallo-Endopeptidase Variant 2,Neprilysin-390,Neprilysin-411,CD10 Antigen,EC 3.4.24.11,CMT2T,SCA43,EPN,MME,Enkephalinase,CALLA,Neutral endopeptidase,Common acute lymphocytic leukemia antigen,Neprilysin,CD10,Membrane Metalloendopeptidase,Neutral Endopeptidase 24.11,Skin fibroblast elastase
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Approved

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
결합물별:
제품번호 제품 설명 구조 순도 특징
MME-H521b Human Human Neprilysin / MME / CD10 Protein, Tag Free (active enzyme)
MME-H521b-structure
MME-H521b-sds
MME-H526a Human Human Neprilysin / MME / CD10 Protein, Fc Tag
MME-H526a-structure
MME-H526a-sds

Synonym Name

MME,CALLA,CD10,DKFZp686O16152,MGC126681,MGC126707,NEP,SFE,Neprilysin

Background

Cluster of differentiation 10 (CD10) is also known as membrane metallo-endopeptidase, neutral endopeptidase (NEP), Neprilysin, and common acute lymphoblastic leukemia antigen (CALLA), is a 90-110-kDa type II transmembrane glycoprotein normally expressed by a variety of tissues, including epithelial cells of the prostate, kidney, intestine, endometrium, adrenal glands, and lung. This zinc-dependent metalloprotease enzyme cleaves peptide bonds on the amino side of hydrophobic residues and inactivates a variety of physiologically active secreted peptides. CD20 is thought to be the rate-limiting degrading enzyme of amyloid ¦Â peptide (A¦Â) whose abnormal misfolding and aggregation in neural tissue has been implicated in the development of Alzheimer's disease (AD). CD10 is also identified as the common acute lymphoblastic leukemia antigen (CALLA) present on leukemic cells of pre-B phenotype, and thus serves as the most important biomarker in the diagnosis of human acute lymphocytic leukemia (ALL).

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Sacubitril/Valsartan Sodium Hydrate LCZ-696; LCZ-696A Approved Novartis Pharma Ag Entresto, 诺欣妥, 科畅欣, Neparvis, ENTRESTO SPRINKLE, Enresuto, Enrest United States Heart Failure Novartis Pharmaceuticals Corp 2015-07-07 Breast Neoplasms; Heart Failure, Systolic; Peripheral Arterial Disease; Ventricular Dysfunction, Left; Lymphoma; Obesity; Cardiovascular Diseases; Hepatic Insufficiency; Essential Hypertension; Erectile Dysfunction; Hypertension; Coronavirus Disease 2019 (COVID-19); Postmyocardial Infarction Syndrome; Heart Diseases; Cardiomyopathy, Hypertrophic; Myocardial Infarction; Renal Insufficiency; Heart Failure Details
Racecadotril Tiorfan; Hidrasec Approved Bioprojet Pharma France Diarrhea Bioprojet Pharma 1993-03-23 Diarrhea, Infantile; Diarrhea Details
Sacubitril/Valsartan Sodium Hydrate LCZ-696; LCZ-696A Approved Novartis Pharma Ag Entresto, 诺欣妥, 科畅欣, Neparvis, ENTRESTO SPRINKLE, Enresuto, Enrest United States Heart Failure Novartis Pharmaceuticals Corp 2015-07-07 Breast Neoplasms; Heart Failure, Systolic; Peripheral Arterial Disease; Ventricular Dysfunction, Left; Lymphoma; Obesity; Cardiovascular Diseases; Hepatic Insufficiency; Essential Hypertension; Erectile Dysfunction; Hypertension; Coronavirus Disease 2019 (COVID-19); Postmyocardial Infarction Syndrome; Heart Diseases; Cardiomyopathy, Hypertrophic; Myocardial Infarction; Renal Insufficiency; Heart Failure Details
Racecadotril Tiorfan; Hidrasec Approved Bioprojet Pharma France Diarrhea Bioprojet Pharma 1993-03-23 Diarrhea, Infantile; Diarrhea Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Dexecadotril Phase 3 Clinical Bioprojet Pharma Gastrointestinal Diseases Details
Debio-0827 PL-37; Debio-0827 Phase 2 Clinical Pharmaleads Pain Details
STR-324 STR-324 Phase 2 Clinical Shanghai Pasteur Institute Of Chinese Academy Of Sciences Acute Pain Details
Sacubitril AHU-377 Phase 2 Clinical Novartis Pharma Ag Heart Failure; Cardiomyopathy, Hypertrophic; Insulin Resistance; Hypertension; Metabolic Diseases; Essential Hypertension; Cardiovascular Diseases; Diabetes Mellitus Details
QR-12000 QR-12000 Phase 2 Clinical Wuhan Createrna Science and Technology Co Ltd Hypertension; Essential Hypertension Details
Dexecadotril Phase 3 Clinical Bioprojet Pharma Gastrointestinal Diseases Details
Debio-0827 PL-37; Debio-0827 Phase 2 Clinical Pharmaleads Pain Details
STR-324 STR-324 Phase 2 Clinical Shanghai Pasteur Institute Of Chinese Academy Of Sciences Acute Pain Details
Sacubitril AHU-377 Phase 2 Clinical Novartis Pharma Ag Heart Failure; Cardiomyopathy, Hypertrophic; Insulin Resistance; Hypertension; Metabolic Diseases; Essential Hypertension; Cardiovascular Diseases; Diabetes Mellitus Details
QR-12000 QR-12000 Phase 2 Clinical Wuhan Createrna Science and Technology Co Ltd Hypertension; Essential Hypertension Details

This web search service is supported by Google Inc.

totop